retatrutide cardiovascular side effects What are reported with Retatrutide? A study of Lilly's retatrutide

Disclosure The authors declare no conflicts of interest

Shi Y, Wang H, Su Z, Chen J, Xue Y, Wang S et al (2010) Differentiation imbalance of Th1/ Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimotos thyroiditis: differentiation imbalance of Th1/Th17 contribute to pathogenesis of HT

Acknowledgements Figures are created with BioRender.com

The ongoing Cardiovascular and Renal Microvascular Outcome study with Linagliptin in patients with T2DM (CARMELINA), which is powered to evaluate kidney outcomes and renoprotective effects of this inhibitor, should begin to fill in a gap in our knowledge regarding the efficacy of DPP-4 inhibitors in T2DM patients with CKD with our without CVD [130]

Whats more, it remained in the bloodstream for hours, not minutes

Clarifying the relative contribution of these processes will be critical for developing more effective and better-targeted interventions